Cargando…

Pharmacogenomics and migraine: possible implications

Pharmacogenomics is the science about how inherited factors influence the effects of drugs. Drug response is always a result of mutually interacting genes with important modifications from environmental and constitutional factors. Based on the genetic variability of pharmacokinetic and in some cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Tfelt-Hansen, Peer, Brøsen, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476174/
https://www.ncbi.nlm.nih.gov/pubmed/18217199
http://dx.doi.org/10.1007/s10194-008-0009-y
_version_ 1782247065728843776
author Tfelt-Hansen, Peer
Brøsen, Kim
author_facet Tfelt-Hansen, Peer
Brøsen, Kim
author_sort Tfelt-Hansen, Peer
collection PubMed
description Pharmacogenomics is the science about how inherited factors influence the effects of drugs. Drug response is always a result of mutually interacting genes with important modifications from environmental and constitutional factors. Based on the genetic variability of pharmacokinetic and in some cases pharmacodynamic variability we mention possible implications for the acute and preventive treatment of migraine. Pharmacogenomics will most likely in the future be one part of our therapeutic armamentarium and will provide a stronger scientific basis for optimizing drug therapy on the basis of each patient’s genetic constitution.
format Online
Article
Text
id pubmed-3476174
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-34761742012-11-29 Pharmacogenomics and migraine: possible implications Tfelt-Hansen, Peer Brøsen, Kim J Headache Pain Review Pharmacogenomics is the science about how inherited factors influence the effects of drugs. Drug response is always a result of mutually interacting genes with important modifications from environmental and constitutional factors. Based on the genetic variability of pharmacokinetic and in some cases pharmacodynamic variability we mention possible implications for the acute and preventive treatment of migraine. Pharmacogenomics will most likely in the future be one part of our therapeutic armamentarium and will provide a stronger scientific basis for optimizing drug therapy on the basis of each patient’s genetic constitution. Springer Milan 2008-01-24 2008-02 /pmc/articles/PMC3476174/ /pubmed/18217199 http://dx.doi.org/10.1007/s10194-008-0009-y Text en © Springer-Verlag 2008
spellingShingle Review
Tfelt-Hansen, Peer
Brøsen, Kim
Pharmacogenomics and migraine: possible implications
title Pharmacogenomics and migraine: possible implications
title_full Pharmacogenomics and migraine: possible implications
title_fullStr Pharmacogenomics and migraine: possible implications
title_full_unstemmed Pharmacogenomics and migraine: possible implications
title_short Pharmacogenomics and migraine: possible implications
title_sort pharmacogenomics and migraine: possible implications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476174/
https://www.ncbi.nlm.nih.gov/pubmed/18217199
http://dx.doi.org/10.1007/s10194-008-0009-y
work_keys_str_mv AT tfelthansenpeer pharmacogenomicsandmigrainepossibleimplications
AT brøsenkim pharmacogenomicsandmigrainepossibleimplications